{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:49:49Z","timestamp":1782773389105,"version":"3.54.5"},"reference-count":0,"publisher":"CMA Joule Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Medical Association Journal"],"published-print":{"date-parts":[[2006,1,17]]},"DOI":"10.1503\/cmaj.051623","type":"journal-article","created":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T02:08:43Z","timestamp":1135130923000},"page":"164-165","source":"Crossref","is-referenced-by-count":3,"title":["The Evra (ethinyl estradiol\/norelgestromin) contraceptive patch: estrogen exposure concerns"],"prefix":"10.1503","volume":"174","author":[{"given":"E.","family":"Wooltorton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","container-title":["Canadian Medical Association Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1503\/cmaj.051623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T16:46:05Z","timestamp":1552927565000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cmaj.ca\/cgi\/doi\/10.1503\/cmaj.051623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,17]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1,17]]}},"URL":"https:\/\/doi.org\/10.1503\/cmaj.051623","relation":{},"ISSN":["0820-3946","1488-2329"],"issn-type":[{"value":"0820-3946","type":"print"},{"value":"1488-2329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,17]]}}}